Harpoon Therapeutics Inc (NASDAQ:HARP)

14.62
Delayed Data
As of Jan 24
 -0.36 / -2.40%
Today’s Change
9.07
Today|||52-Week Range
21.47
-1.15%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Harpoon Therapeutics Inc have a median target of 25.50, with a high estimate of 28.00 and a low estimate of 23.00. The median estimate represents a +74.42% increase from the last price of 14.62.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Harpoon Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.62
Sales
$26.3M
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.64%
 
 
 
 
 
 
Growthannually 87.73%
 
 
 

Sales

Growthquarterly 1,752.51%
 
 
 
 
 
 
Growthannually 527.59%
 
 
 
Key to the earnings and sales forecast charts.